Brenipatide for major depressive disorder
Treatments studied
Part of Mental health clinical trials.
This trial tests a new medication, Brenipatide, to see if it helps people with major depression who are already on a stable treatment. You would need to inject the study drug yourself and complete questionnaires.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of major depressive disorder
- You are taking a stable dose of your current depression medication
- You are willing to self-inject the study drug and keep an electronic diary
- You do not have a history of schizophrenia, bipolar disorder, borderline personality disorder, or an eating disorder
- You do not have type 1 diabetes or a history of diabetes-related emergencies
- You do not have moderate or severe substance or alcohol problems in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called brenipatide for major depressive disorder. It is given as a self-injection and is being compared to a placebo to see if it helps improve depression symptoms in people who are already on standard treatment.
This trial tests an experimental drug called brenipatide for people with bipolar I or II disorder. It aims to see if the drug can help manage mood episodes when added to your current stable medications.
This trial tests a new medication (NBI-1065845) added to your current antidepressant to see if it helps maintain improvement in depression. It is for people whose depression hasn't fully responded to their current oral antidepressant.
This trial tests an investigational drug called NBI-1065845 added to your current antidepressant. It is for people with moderate to severe depression or persistent depressive disorder who have not improved enough with oral antidepressants alone.
This trial tests an investigational drug called brenipatide for people with schizophrenia who are already on a stable medication regimen. The goal is to see if adding this drug helps reduce relapses.
This trial tests a new medicine called Brenipatide for people with opioid use disorder who are already taking buprenorphine but still occasionally use non-prescribed opioids. It aims to see if the study drug can help reduce opioid use.
Hear when a new Depressive Disorder, Major trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.